Continuous Monitoring Outperforms Fingerstick Testing in Patients With T1D, High Glycated Hemoglobin
New evidence supports the use of continuous glucose monitoring as a means to help control glycated hemoglobin levels in people with type 1 diabetes (T1D). The study, which compared continuous ...
A world-first Australian trial has found that a simple fingerstick test for hepatitis B DNA is as accurate as standard lab testing, paving the way for wider access in remote and resource-limited ...
STOCKHOLM, Sweden — Whether continuous glucose monitoring (CGM) is for "all" — and if not, for whom — was the topic of a lively debate at the recent European Association for the Study of Diabetes ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
According to World Health Organization estimates, around 254 million people were living with chronic hepatitis B infection in 2022. Yet only 14 percent had been diagnosed, and just 8 percent were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results